• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

ABCELLERA BIOLOGICS INC.

Notes

No. Proposition For Against Abstain
1

Election of class III Director to serve until the 2029 Annual Meeting of Shareholders or until their successors has been duly elected and qualified, or until their earlier death, resignation or removal: John S. Montalbano, CFA

2

Election of class III Director to serve until the 2029 Annual Meeting of Shareholders or until their successors has been duly elected and qualified, or until their earlier death, resignation or removal: Stephen R. Quake, D.Phil.

3

To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

4

To approve, on a non-binding advisory basis, the compensation of the Companys named executive officers, or Say-on-Pay.